Search for: "SUN PHARMACEUTICAL V ELI LILLY"
Results 1 - 20
of 60
Sorted by Relevance
|
Sort by Date
16 May 2011, 9:46 pm
Noonan -- The Supreme Court refused today to grant certiorari in Eli Lilly & Co. v. [read post]
1 Nov 2010, 2:10 pm
By Jason Rantanen Sun Pharmaceutical Industries, Ltd. v. [read post]
2 Aug 2010, 5:00 am
Sun Pharmaceutical Industries, Ltd. v. [read post]
29 Jul 2010, 9:59 pm
Eli Lilly & Co., the Federal Circuit affirmed a finding that claims of Lilly's U.S. [read post]
30 Sep 2010, 9:59 pm
Noonan -- The Biotechnology Industry Organization (BIO) has joined the chorus of amici urging the Federal Circuit to rehear en banc (and overturn) a panel decision affirming an invalidity finding of Eli Lilly's U.S. [read post]
23 Sep 2010, 9:37 pm
Noonan -- The Washington Legal Foundation (WLF), a self-styled "non-profit public interest law and policy center that regularly appears before federal and state courts to promote economic liberty, free enterprise, and a limited and accountable government," filed an amicus curiae brief on September 8th, urging the Federal Circuit to rehear en banc Eli Lilly's appeal of the Court's affirmance of an invalidity finding of U.S. [read post]
28 Jul 2010, 2:32 pm
Sun Pharmaceutical Industries, Ltd. v. [read post]
18 Mar 2011, 12:38 pm
The petition of the day is: Title: Eli Lilly and Company v. [read post]
4 Nov 2010, 9:13 pm
Eli Lilly & Co., No. 2010-1105 (Fed. [read post]
5 Aug 2010, 2:03 pm
See, Sun Pharmaceutical Industries v. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories,… [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.;… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.;… [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against… [read post]
4 Aug 2010, 12:21 am
(Patent Docs) Gemzar (Gemcitabine) – US: CAFC affirms invalidity of Lilly’s Gemzar patent for obviousness-type double patenting: Sun Pharmaceuticals v. [read post]
20 May 2011, 11:15 pm
(FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
3 Nov 2010, 1:21 am
Highlights this week included: US Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) Gemzar (Gemcitabine) – US: CAFC denies en banc rehearing of ‘distorted’ law of double-patenting: Sun Pharmaceuticals v Eli… [read post]
2 Feb 2011, 3:52 am
General Technical symposium to address access to medicines, patent information and freedom to operate (WIPO) Brazil: Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) India: Protection of Plant Varieties and Farmers’ Rights Authority appoints new Chairperson (Spicy IP) Italy: Tribunale di Milano: Mere filing of application for marketing authorization of a generic drug does not constitute infringing activity:… [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin… [read post]
18 Aug 2010, 12:19 am
Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind. [read post]
